UPDATE : Thursday, July 18, 2019
상단여백
Keytruda wins nod as adjuvant therapy after melanoma surgery
The Ministry of Food and Drug Safety has approved PD-1 inhibitor immunother...
by Kim Yun-mi  |  2019-05-15 14:14
라인
EU lists Korea on drug standard whitelist
Korea's medical export to the European Union is expected to see strong ...
by Lee Han-soo  |  2019-05-15 13:25
라인
J&J's nasal spray depression treatment still met with some skepticism
Johnson & Johnson's Spravato (ingredient: esketamine), a new nasal spra...
by Lee Han-soo  |  2019-05-14 15:26
라인
‘MSD Korea’s foreign exec got drunk, sexually harassed female worker’
A foreign executive at MSD Korea not only sexually harassed a female employ...
by Jeong Sae-im  |  2019-05-14 11:53
라인
Korean companies excel multinational pharma’s R&D in investment-sales ratio
Local pharmaceutical companies surpassed multinational giants in research a...
by Lee Han-soo  |  2019-05-13 17:27
라인
Chinese patients vaccinate MSD’s product in Korea. Why?
An increasing number of Chinese female patients are visiting Korean obstetr...
by Lee Han-soo  |  2019-05-13 14:57
라인
US trade agency orders Daewoong to submit Nabota’s strain
The prolonged dispute between Medytox and Daewoong over the origin of Nabot...
by Lee Han-soo  |  2019-05-13 14:37
라인
Antibody-drug conjugates on the rise as Herceptin’s patent to expire soon
With Roche’s HER2-positive breast cancer drug Herceptin (trastuzumab) facin...
by Kim Yun-mi  |  2019-05-13 14:23
라인
Pfizer keeps lead over multinational pharmas in 2018 sales
Multinational pharmaceutical companies have shown mixed results in their sa...
by Lee Han-soo  |  2019-05-10 17:17
라인
Xeljianz is easier to use than biologic therapies -- is it safer, however?
Pfizer’s Xeljianz (tofacitinib), an oral Janus kinase (JAK) inhibitor to tr...
by Kim Yun-mi  |  2019-05-10 15:34
라인
[Exclusive] MSD Korea playing tricks to reduce daycare cost
Korea Biomedical Review ran an exclusive story on an executive at MSD Korea...
by Kim Yun-mi  |  2019-05-09 11:20
라인
T&R Biofab, CiSTEM to co-develop rare disease treatments
T&R Biofab and CiSTEM have signed a technology transfer contract to develop...
by Lee Han-soo  |  2019-05-09 11:17
라인
‘GC Wellbeing’s placenta injection has liver regenerative effects’
GC Wellbeing, a subsidiary of GC, has released the results of a study regar...
by Lee Han-soo  |  2019-05-08 17:07
라인
Celgene’s myelodysplastic syndrome treatment gets more insurance benefits
The Ministry of Health and Welfare has granted additional reimbursement to ...
by Lee Han-soo  |  2019-05-07 17:36
라인
GC Cell to start developing CAR-T treatment for pancreatic cancer
GC Cell has concluded a material transfer agreement with Mogam Institute fo...
by Lee Han-soo  |  2019-05-07 16:10
라인
FDA OKs Gemvax & Kael's Alzheimer treatment for P2 trials
Gemvax & Kael has obtained U.S. Food and Drug Administration's investig...
by Lee Han-soo  |  2019-05-07 16:09
라인
[Exclusive] MSD workers appalled by executive’s remarks on childcare leave
MSD Korea recently revised a policy to allow employees on child care leave ...
by Jeong Sae-im  |  2019-05-07 12:08
라인
Dong-A ST posts robust Q1 profit
Dong-A ST said Friday that it recorded sales of 142.6 billion won ($121.8 m...
by Lee Han-soo  |  2019-05-03 16:49
라인
Leading hepatitis C drug wins FDA nod for adolescents
AbbVie’s hepatitis C treatment Mavyret (glecaprevir/pibrentasvir), which wo...
by Kim Yun-mi  |  2019-05-03 15:51
라인
GC surpasses 200-million mark in flu vaccine production
GC has become the first local company to manufacture more than 200 million ...
by Lee Han-soo  |  2019-05-03 14:39
여백
여백
여백
Back to Top